Natixis Advisors L.P. Purchases 154,936 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Natixis Advisors L.P. boosted its position in Definitive Healthcare Corp. (NASDAQ:DHGet Rating) by 228.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 222,759 shares of the company’s stock after buying an additional 154,936 shares during the period. Natixis Advisors L.P. owned approximately 0.23% of Definitive Healthcare worth $5,491,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Kayne Anderson Rudnick Investment Management LLC boosted its stake in shares of Definitive Healthcare by 216.0% in the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 644,222 shares of the company’s stock worth $17,607,000 after buying an additional 440,377 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Definitive Healthcare by 161.0% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 680,033 shares of the company’s stock valued at $18,585,000 after acquiring an additional 419,444 shares during the period. George Kaiser Family Foundation bought a new stake in Definitive Healthcare during the 1st quarter valued at $507,000. Pentwater Capital Management LP bought a new position in shares of Definitive Healthcare in the fourth quarter worth $1,640,000. Finally, Allspring Global Investments Holdings LLC bought a new position in shares of Definitive Healthcare in the first quarter worth $529,000.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on DH. Barclays decreased their price target on shares of Definitive Healthcare from $24.00 to $23.00 and set an “equal weight” rating on the stock in a report on Monday, August 8th. Needham & Company LLC began coverage on shares of Definitive Healthcare in a report on Wednesday, July 6th. They issued a “buy” rating and a $30.00 price target on the stock. Finally, Morgan Stanley decreased their price target on shares of Definitive Healthcare from $37.00 to $34.00 and set an “overweight” rating on the stock in a report on Monday, August 8th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $35.92.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $18.84 on Monday. The company has a 50-day simple moving average of $23.86 and a two-hundred day simple moving average of $22.40. The company has a quick ratio of 3.32, a current ratio of 3.32 and a debt-to-equity ratio of 0.18. Definitive Healthcare Corp. has a 12-month low of $14.76 and a 12-month high of $50.30. The firm has a market cap of $1.89 billion and a price-to-earnings ratio of -57.09.

Insider Transactions at Definitive Healthcare

In other Definitive Healthcare news, Director David Randall Winn sold 2,200,000 shares of the firm’s stock in a transaction that occurred on Monday, August 8th. The shares were sold at an average price of $24.02, for a total transaction of $52,844,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 17.52% of the stock is currently owned by company insiders.

About Definitive Healthcare

(Get Rating)

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.

Featured Articles

Want to see what other hedge funds are holding DH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Definitive Healthcare Corp. (NASDAQ:DHGet Rating).

Institutional Ownership by Quarter for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.